These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 29378302)
1. Amyloid-β oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's disease. Vargas LM; Cerpa W; Muñoz FJ; Zanlungo S; Alvarez AR Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1148-1159. PubMed ID: 29378302 [TBL] [Abstract][Full Text] [Related]
2. EphA4 activation of c-Abl mediates synaptic loss and LTP blockade caused by amyloid-β oligomers. Vargas LM; Leal N; Estrada LD; González A; Serrano F; Araya K; Gysling K; Inestrosa NC; Pasquale EB; Alvarez AR PLoS One; 2014; 9(3):e92309. PubMed ID: 24658113 [TBL] [Abstract][Full Text] [Related]
3. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease. Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046 [TBL] [Abstract][Full Text] [Related]
5. Drebrin in Alzheimer's Disease. Ishizuka Y; Hanamura K Adv Exp Med Biol; 2017; 1006():203-223. PubMed ID: 28865022 [TBL] [Abstract][Full Text] [Related]
6. Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer's disease. Fu AK; Hung KW; Huang H; Gu S; Shen Y; Cheng EY; Ip FC; Huang X; Fu WY; Ip NY Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9959-64. PubMed ID: 24958880 [TBL] [Abstract][Full Text] [Related]
7. c-Abl Deficiency Provides Synaptic Resiliency Against Aβ-Oligomers. Gutierrez DA; Vargas LM; Chandia-Cristi A; de la Fuente C; Leal N; Alvarez AR Front Cell Neurosci; 2019; 13():526. PubMed ID: 31849613 [TBL] [Abstract][Full Text] [Related]
8. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis. Viola KL; Klein WL Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547 [TBL] [Abstract][Full Text] [Related]
9. Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice. Brito-Moreira J; Lourenco MV; Oliveira MM; Ribeiro FC; Ledo JH; Diniz LP; Vital JFS; Magdesian MH; Melo HM; Barros-Aragão F; de Souza JM; Alves-Leon SV; Gomes FCA; Clarke JR; Figueiredo CP; De Felice FG; Ferreira ST J Biol Chem; 2017 May; 292(18):7327-7337. PubMed ID: 28283575 [TBL] [Abstract][Full Text] [Related]
10. Signaling via the p75 neurotrophin receptor facilitates amyloid-β-induced dendritic spine pathology. Patnaik A; Zagrebelsky M; Korte M; Holz A Sci Rep; 2020 Aug; 10(1):13322. PubMed ID: 32770070 [TBL] [Abstract][Full Text] [Related]
11. SORLA attenuates EphA4 signaling and amyloid β-induced neurodegeneration. Huang TY; Zhao Y; Jiang LL; Li X; Liu Y; Sun Y; Piña-Crespo JC; Zhu B; Masliah E; Willnow TE; Pasquale EB; Xu H J Exp Med; 2017 Dec; 214(12):3669-3685. PubMed ID: 29114064 [TBL] [Abstract][Full Text] [Related]
12. Synaptotoxicity in Alzheimer's Disease Involved a Dysregulation of Actin Cytoskeleton Dynamics through Cofilin 1 Phosphorylation. Rush T; Martinez-Hernandez J; Dollmeyer M; Frandemiche ML; Borel E; Boisseau S; Jacquier-Sarlin M; Buisson A J Neurosci; 2018 Nov; 38(48):10349-10361. PubMed ID: 30341179 [TBL] [Abstract][Full Text] [Related]
13. Effect of Aβ Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons. Rolland M; Powell R; Jacquier-Sarlin M; Boisseau S; Reynaud-Dulaurier R; Martinez-Hernandez J; André L; Borel E; Buisson A; Lanté F J Neurosci; 2020 Jul; 40(27):5161-5176. PubMed ID: 32444385 [TBL] [Abstract][Full Text] [Related]